TherMatrx Thermo Therapy TherMatrx Thermo Therapy is appropriate for men with symptomatic BPH who are not satisfied with the results or side effects of their current BPH treatment choice. TherMatrx is ideal for patients who are interested in a one-time, non-surgical treatment and are concerned about treatment safety and sexual side effects.1 Additionally, TherMatrx does not prohibit concomitant use with erectile dysfunction medication.
TherMatrx is Best For Patients With:
Normal bladder function- Normal prostate anatomy
- True BPH:
- Rule out overactive bladder, cancer, prostatitis
- Prostates between 30 and 100 grams1
- PVR greater than 125 ml
- AUA Symptom score greater than 12
- Minimum bladder neck to verumontanum length of 3 cm
- Patients who perform well on medical therapy, but want better symptom relief or want to stop taking medications
- Patients in early stages of BPH
Patients with these criteria have the best opportunity for:
- Fast symptom relief1
- Long-lasting symptom relief1,3
Note: It is important to use the correct catheter size for the best outcomes.
- Patients with peripheral arterial disease with intermittent claudication or Leriches syndrome (i.e., claudication of the buttocks and perineum).
- Patients with severe urethral strictures, preventing easy catheterization.
- Patients with implanted defibrillators, pacemakers, or any other active implant.
- Patients with a penile or urinary sphincter implant.
- Patients with a metallic implant in the prostatic treatment area, pelvis, or hip.
- Patients with a minimum prostatic urethra length <25mm and a total prostate volume <30 or >100 cc.
- Patients who have undergone prior radiation therapy to the pelvic region.
For a complete list of indications, contraindications, warnings and precautions, refer to the Instructions for Use for the TMX3000™ or contact your AMS representative. This content is written for professional medical audiences. Contact your AMS representative for lay publications. AMS periodically updates product literature. If you have any questions regarding the this information, please contact AMS.
1. Transurethral Microwave Thermotherapy System. TherMatrx TMx-2000™. PMA P000043 summary of safety and effectiveness data. Approved June 29, 2001. Available at: www.fda.gov/cdrh/pdf/p000043.html.
3. Albala D, Andriole G, Davis B, Eure G, Kabalin J, Lingeman J, Nuzzarello. Transurethral microwave thermotherapy (TUMT) using the TherMatrx TMX-2000ª for treatement of benign prostatic hyperplasia: 5-year follow-up of multicentre randomised pivotal trial. Eur Urol Apr 2006;5(2 suppl.):234 abstract 846.
[ BPH Thermo Therapy TherMatrx Patient Selection Reimbursement Training Equip Eval. Clinical Studies Calendar Contact Us] [ Home ]